Education
About Us
Working with TipRanks
Follow Us
Spectral AI (MDAI)
NASDAQ:MDAI
MDAI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.82 - $3.25
Previous CloseN/A
Volume689.87K
Average Volume (3M)383.29K
Market Cap
$31.39M
Enterprise Value$52.77M
Total Cash (Recent Filing)$769.43K
Total Debt (Recent Filing)$16.15K
Price to Earnings (P/E)―
Beta0.48
Next Earnings
May 13, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding25,317,196
10 Day Avg. Volume288,816
30 Day Avg. Volume383,294
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.16
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.70
Enterprise Value/Ebitda-7.50
Forecast
1Y Price Target
$4.17Price Target Upside236.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Spectral AI News
PremiumCompany Announcements
Spectral AI Enhances CFO Compensation Amidst Growth
PremiumCompany Announcements
Spectral AI Earnings Call: Tech Triumphs Amid Financial Hurdles
PremiumCompany Announcements
Spectral AI Reports Strong 2024 Financial Results
PremiumCompany Announcements
Spectral AI Secures $15M Financing for U.S. Expansion---
Bulls Say, Bears Say
Bulls Say
Clinical ValidationSignificantly higher accuracy of the DeepView system in identifying non-healing burn tissue compared to physician evaluation highlights its clinical potential.
Financial PerformanceSpectral AI's reported revenues of $8.2M for 3Q24 exceeded estimates, indicating strong financial performance.
Regulatory ApprovalThe company's plan to submit the 510(k) de novo application to the FDA for the DeepView system could pave the way for a successful US market entry.
Bears Say
Market CompetitionThe presence of competition in the market poses a challenge to the company's commercial success.
Operational RisksPotential risks include clinical, competition, regulatory, commercial, legal and intellectual property, manufacturing, and dilution challenges.
Revenue GuidanceManagement's 2025 revenue guidance indicates an expected decrease from 2024 as the company prioritizes regulatory approval.
---
Ownership Overview
29.05% Insiders
0.75% Mutual Funds
7.52% Other Institutional Investors
60.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
MDAI FAQ
What was Spectral AI’s price range in the past 12 months?
Spectral AI lowest stock price was $0.82 and its highest was $3.25 in the past 12 months.
What is Spectral AI’s market cap?
Spectral AI’s market cap is $31.39M.
When is Spectral AI’s upcoming earnings report date?
Spectral AI’s upcoming earnings report date is May 13, 2025 which is in 21 days.
How were Spectral AI’s earnings last quarter?
Spectral AI released its earnings results on Mar 27, 2025. The company reported -$0.41 earnings per share for the quarter, missing the consensus estimate of -$0.121 by -$0.289.
Is Spectral AI overvalued?
According to Wall Street analysts Spectral AI’s price is currently Undervalued.
Does Spectral AI pay dividends?
Spectral AI does not currently pay dividends.
What is Spectral AI’s EPS estimate?
Spectral AI’s EPS estimate is -0.13.
How many shares outstanding does Spectral AI have?
Spectral AI has 25,317,196 shares outstanding.
What happened to Spectral AI’s price movement after its last earnings report?
Spectral AI reported an EPS of -$0.41 in its last earnings report, missing expectations of -$0.121. Following the earnings report the stock price went down -11.719%.
Which hedge fund is a major shareholder of Spectral AI?
Among the largest hedge funds holding Spectral AI’s share is Saba Capital Management. It holds Spectral AI’s shares valued at 0.
---
Spectral AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.17 (236.29% Upside)
$4.17 (236.29% Upside)
Blogger Sentiment
Bullish
MDAI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 4.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.07%
12-Months-Change
Fundamentals
Return on Equity
256.43%
Trailing 12-Months
Asset Growth
13.12%
Trailing 12-Months
Company Description
Spectral AI
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
---
MDAI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in technology validation and revenue growth, particularly with the DeepView system's performance and international deployments. However, financial challenges and projected revenue declines for 2025 temper the optimistic outlook.Read More>---
MDAI Stock 12 Month Forecast
Average Price Target
$4.17
▲(236.29% Upside)
Technical Analysis
iCAD
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vicarious Surgical
―
Hyperfine
―
Best Analysts Covering MDAI
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-15.40%
reiterated a buy rating 21 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -15.40% per trade.
---